We are live on ! Find out more
GC

Gullane Capital Portfolio holdings

AUM $37.4M
1-Year Est. Return 112.18%
This Fund
S&P 500
This Quarter Est. Return
+140.77%
1 Year Est. Return
+112.18%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$188M
AUM Growth
+$108M
Cap. Flow
-$4.36M
Cap. Flow %
-2.32%
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
2
Reduced
1
Closed

Top Buys

Rank Stock Value
1
CORZ icon
Core Scientific
CORZ
+$2.86M

Top Sells

Rank Stock Value
1
CORZW icon
Core Scientific Inc Tranche 1 Warrants
CORZW
+$7.32M

Sector Composition

Rank Sector Weight
1 Technology 93.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CORZ icon
1
Core Scientific
CORZ
$6.66B
$176M 93.61%
10,324,773
+285,897
+3% +$2.86M
CORZW icon
2
Core Scientific Inc Tranche 1 Warrants
CORZW
$1.38B
$8.01M 4.25%
738,734
-1,472,759
-67% -$7.32M
CORZ icon
3
CALL
Core Scientific
CORZ
$6.66B
$3.29M 1.75%
10,001
+7,901
+376% +$79.1K
PLTR icon
4
Palantir
PLTR
$295B
$713K 0.38%
5,232
CORZ icon
5
PUT
Core Scientific
CORZ
$6.66B
$17.1K 0.01%
+2,000
New +$20K

Similar funds

Gullane Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Gullane Capital held 5 positions worth $188M, up 136% from $79.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Gullane Capital's Q2 2025 filing shows 1 new, 2 increased and 1 reduced positions. The largest sale was Core Scientific Inc Tranche 1 Warrants, an estimated $7.32M.

By sector, the portfolio is most concentrated in Technology at 94% of assets, up from 92% a quarter earlier.

  • Gullane Capital added most to Core Scientific in Q2 2025, an estimated $2.86M increase.
  • Gullane Capital's biggest Q2 2025 reduction was Core Scientific Inc Tranche 1 Warrants, cutting an estimated $7.32M.
  • Gullane Capital's ten largest holdings make up 100% of its $188M portfolio in Q2 2025.
  • Gullane Capital opened 1 new position and closed 0 in Q2 2025.
  • Gullane Capital's portfolio value rose 136% quarter-over-quarter to $188M.

Based on Gullane Capital's 13F filing for Q2 2025, filed 2 Sep 2025.